Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancerLihua Wang(Wenzhou Medical University), Tongke Chen(Wenzhou Medical University)Journal of Experimental & Clinical Cancer ResearchNovember 8, 201910.1186/s13046-019-1424-4Cited by 194SaveCiteExport RISWatch citationsRelated PapersMicroRNA-182 Suppresses HGF/SF-Induced Increases in Retinal Pigment Epithelial Cell Proliferation and Migration through Targeting c-Met|PLoS ONE|2016|26A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming|Journal of Translational Medicine|2022|10WZ35 Induces Metabolic Reprogramming of Hepatoma Cells Through ROS-Mediated Inhibition of YAP-GLUT1 Axis|Research Square|2021|0